GIANTT

Groningen Initiative to ANalyse Type 2 diabetes Treatment...

Description

Dynamic cohort with routinely collected prescription and diagnostic data for people with type 2 diabetes mellitus...

General Design

Cohort type

Clinical cohort

Design

Longitudinal

Design description

Dynamic cohort of T2DM patients from various general practices

Collection type

Retrospective, Prospective

Start/End year

2004 - ongoing

PID

https://doi.org/10.34760/652666d663240

Population

Countries

Netherlands (the)

Regions

Groningen

Number of participants

64000

Number of participants with samples

0

Population age groups

Adult (18+ years)

Main medical condition
  • IV Endocrine, nutritional and metabolic diseases

Contributors

Available Data & Samples

Data categories

  • Medical records

Areas of information

  • Laboratory measures
  • Socio-demographic and economic characteristics
  • Medication and supplements
  • Physical measures and assessments

Subpopulations

List of subcohorts or subpopulations for this resource...

Collection events

List of collection events defined for this resource...

Access conditions

Request for use must be approved by steering committee....

Data access conditions

health or medical or biomedical research

Data use conditions
  • project specific restriction
  • return to database or resource
Data access fee

true

Release type
  • Periodically
Release description

Request to be assessed by GIANTT steering committee

Linkage options

No linkage options.

Funding & Acknowledgements

Acknowledgements

This research has been conducted using anonymous data collected from the Groningen Initiative to ANalyse Type 2 diabetes Treatment (GIANTT) database (www.giantt.nl). This longitudinal database contains data from electronic medical records, including prescription data, comorbidity and event data, routine laboratory test results and physical examinations, for patients with type 2 diabetes managed in primary care in the north of the Netherlands (<1% opted out). In The Netherlands, no approval of an ethics committee is needed for studies using anonymous data from medical records.

Documentation